Latest News about WST
Recent news which mentions WST
West Pharmaceutical's Q4 Performance Surpass Expectations, Expects FY22 Sales To Increase 8%
February 17, 2022
Tickers
WST
From Benzinga
Earnings Scheduled For February 17, 2022
February 17, 2022
From Benzinga
The Week Ahead In Biotech (Feb. 13-19): Agios FDA Meeting, Avenue Adcom, Earnings And More
February 13, 2022
From Benzinga
West Pharmaceutical Servs's Ex-Dividend Date Is Monday, Here's What You Need To Know
January 13, 2022
Tickers
WST
From Benzinga
From MarketWatch
Here's How Much You Would Have Made Owning West Pharmaceutical Servs Stock In The Last 15 Years
November 09, 2021
Tickers
WST
From Benzinga
From Benzinga
West Pharmaceutical Services (WST) Q3 2021 Earnings Call Transcript
October 28, 2021
Tickers
WST
From Motley Fool
Earnings Scheduled For October 28, 2021
October 28, 2021
From Benzinga
A California investment firm went from near ruin to managing over $100 billion: Its turnaround may offer solutions to the ‘Great Resignation’
October 08, 2021
From MarketWatch
3 Healthcare Stocks to Buy and Hold for the Next 10 Years
September 30, 2021
From Motley Fool
These high-flying stocks of 2021 have dropped the most today
September 28, 2021
From MarketWatch
3 Best ESG Stocks for Those Committed to Sustainable Investing
September 23, 2021
From InvestorPlace
The Daily Biotech Pulse: Apellis Sinks On Data, Endo Shines On Opioid Litigation Settlement, T2 Biosystems Soars On Mutant Detection Ability of COVID Test
September 10, 2021
From Benzinga
The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization
September 09, 2021
From Benzinga
7 Top-Performing S&P 500 Stocks to Watch
September 08, 2021
From InvestorPlace
The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself
September 03, 2021
From Benzinga
The Daily Biotech Pulse: Merck Releases Twin Dose Of Positive Tidings, Astellas Voluntarily Pauses Gene Therapy Study, Ascendis Offering
September 01, 2021
From Benzinga
From Benzinga
From Benzinga
The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data
August 20, 2021
From Benzinga
Stocks That Hit 52-Week Highs On Thursday
August 19, 2021
From Benzinga
From Benzinga
Stocks That Hit 52-Week Highs On Wednesday
August 18, 2021
From Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.